Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATOMOXETINE | 100MG | CAPSULE | Resolved | 2019-03-06 | 2019-05-04 | 77941 |
| ATOMOXETINE | 100MG | CAPSULE | Resolved | 2023-07-31 | 2023-08-29 | 200453 |
| BETAHISTINE | 24MG | TABLET | Resolved | 2019-03-29 | 2019-07-26 | 79889 |
| BETAHISTINE | 24MG | TABLET | Resolved | 2019-04-10 | 2019-11-13 | 81154 |
| ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2019-01-28 | 2019-03-28 | 73682 |
| ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2019-07-12 | 2019-09-07 | 89173 |
| PERINDOPRIL ERBUMINE | 2MG | TABLET | Resolved | 2024-02-28 | 2024-03-08 | 220840 |
| PERINDOPRIL ERBUMINE | 8MG | TABLET | Resolved | 2023-11-22 | 2023-12-01 | 211058 |
| PERINDOPRIL ERBUMINE | 8MG | TABLET | Resolved | 2024-01-17 | 2024-02-15 | 216247 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-08-22 | 2024-01-30 | 202687 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-22 | 2024-01-30 | 211052 |
| OLMESARTAN | 20MG | TABLET | Resolved | 2023-07-31 | 2024-01-17 | 200465 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-07-31 | 2023-09-25 | 200456 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
| TADALAFIL | 5MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200477 |
| TADALAFIL | 20MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200474 |
| LACOSAMIDE | 100MG | TABLET | Resolved | 2023-07-31 | 2023-11-06 | 200437 |
| LACOSAMIDE | 150MG | TABLET | Resolved | 2023-11-22 | 2024-01-30 | 211034 |
| PROGESTERONE | 100MG | CAPSULE | Resolved | 2023-08-29 | 2023-09-25 | 203121 |
| RIZATRIPTAN | 10MG | TABLET | Resolved | 2023-07-31 | 2023-08-28 | 200440 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |